Cleveland Clinic Taussig Cancer Institute

Taussig Cancer Institute is the hub for Cleveland Clinic Cancer Center.


 

2019 ASH Review on MDS: Luspatercept Under FDA Review, Novel Oral HMT Are Emerging and May Become Basis of New Backbone Therapy for Pts With MDS and AML

19 views
April 14, 2020
0 Comments
Login to view comments. Click here to Login
Malignant Hematology